Seven Fleet Capital Management »

Enliven Therapeutics shares owned by Seven Fleet Capital Management

Quarter-by-quarter ownership of Enliven Therapeutics shares owned by Seven Fleet Capital Management from 13F filings

Historical chart of Seven Fleet Capital Management investment in Enliven Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Enliven Therapeutics held by Seven Fleet Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enliven Therapeutics by Seven Fleet Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $3.7M 95k 39.20

More positions owned by Seven Fleet Capital Management

Cg Oncology
Tango Therapeutics (TNGX)
Revolution Medicines (RVMD)
Tyra Biosciences (TYRA)
Liquidia Corporation Com New (LQDA)
Agios Pharmaceuticals (AGIO)
Century Therapeutics (IPSC)
Enliven Therapeutics (ELVN)
Vaxcyte (PCVX)
Tango Therapeutics
Cogent Biosciences (COGT)
Avalo Therapeutics Com New
Minerva Neurosciences Com New
Cg Oncology (CGON)
Pharvaris N V (PHVS)

View all positions for Seven Fleet Capital Management

Top funds holding Enliven Therapeutics

Seven Fleet Capital Management

View all funds holding Enliven Therapeutics